Physician profile
Suma Dasari
NPI 1518166719
$8,395.86
in general payments reported to CMS, 2019-2025
35 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,784 · 2020: $601 · 2021: $1,342 · 2022: $1,899 · 2023: $1,984 · 2024: $647 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,745 · Education: $25.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,744.57 |
| Education | $25.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,488.86 | 2019-2024 | Rinvoq, Skyrizi, Humira |
| Amgen INC. | $1,164.90 | 2019-2024 | Enbrel, Otezla, Evenity |
| Novartis Pharmaceuticals Corporation | $869.80 | 2019-2025 | |
| Glaxosmithkline, LLC. | $732.35 | 2019-2024 | Benlysta |
| Janssen Biotech, INC. | $725.00 | 2019-2024 | Tremfya, Simponi Aria, Simponi |
| Pfizer INC. | $430.18 | 2019-2024 | |
| Ucb, INC. | $343.57 | 2019-2024 | Cimzia |
| Horizon Therapeutics Plc | $297.35 | 2019-2023 | Krystexxa |
| Lilly USA, LLC | $268.94 | 2019-2024 | Taltz |
| Astrazeneca Pharmaceuticals LP | $212.33 | 2021-2024 | Saphnelo |
| Mallinckrodt Hospital Products INC. | $190.74 | 2021-2024 | Acthar |
| Hikma Pharmaceuticals USA | $181.45 | 2019-2022 | |
| Genzyme Corporation | $168.73 | 2019-2023 | |
| Sobi, INC | $163.73 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.26 | 2019-2024 | Ofev |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $135.35 | 2021-2024 | Lupkynis |
| Merck Sharp & Dohme LLC | $99.58 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $92.89 | 2019-2021 | |
| Alvogen INC | $82.51 | 2023 | Teriparatide |
| Organon LLC | $72.69 | 2021-2023 | Hadlima, Renflexis |
| Genentech USA, INC. | $66.80 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $66.53 | 2023-2024 | Opsumit |
| Sandoz INC. | $58.89 | 2023 | Hyrimoz |
| Kowa Pharmaceuticals America, INC. | $57.78 | 2023 | Seglentis |
| Radius Health, INC. | $43.11 | 2019 | |
| Octapharma USA, INC. | $42.27 | 2021-2022 | |
| Pacira Therapeutics, INC. | $39.74 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $31.50 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $29.82 | 2021 | |
| Celltrion USA INC. | $17.00 | 2023 | Yuflyma |
| Janssen Scientific Affairs, LLC | $16.76 | 2019 | |
| Kyowa Kirin, INC. | $16.33 | 2024 | Crysvita |
| Kiniksa Pharmaceuticals, LTD. | $15.90 | 2023 | Arcalyst |
| Gilead Sciences, INC. | $15.59 | 2024 | Veklury |
| Mylan Institutional INC. | $13.63 | 2023 | Hulio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suma Dasari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.